PUBLICATION

Small molecule screening in the zebrafish

Authors
Murphey, R.D., and Zon, L.I.
ID
ZDB-PUB-060807-5
Date
2006
Source
Methods (San Diego, Calif.)   39(3): 255-261 (Journal)
Registered Authors
Zon, Leonard I.
Keywords
Zebrafish, Embryos, Chemical genetics, Small molecule, Drug screen
MeSH Terms
  • Animals
  • Drug Evaluation, Preclinical/instrumentation
  • Drug Evaluation, Preclinical/methods*
  • Embryo, Nonmammalian/drug effects
  • Genotype
  • Toxicity Tests/instrumentation
  • Toxicity Tests/methods
  • Zebrafish/embryology*
  • Zebrafish/genetics
PubMed
16877005 Full text @ Methods
Abstract
The zebrafish is an ideal organism for small molecule studies. The ability to use the whole organism allows complex in vivo phenotypes to be assayed and combines animal testing with screening. Embryos are easily treatable by waterborne exposure. The small size and abundance of embryos make zebrafish suitable for screening in a high-throughput manner in 96- or 48-well plates. Zebrafish embryos have successfully been used in chemical genetic screens to elucidate biological pathways and find chemical suppressors. Small molecules discovered by screening zebrafish disease models may also be useful as lead compounds for drug development as there appears to be a high level of conservation of drug activity between mammals and zebrafish. Here we provide the technical aspects of treating embryos with small molecules and performing chemical screens with zebrafish.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping